Lung Cancer | Addressing Current Questions and Controversies in the Management of Non-Small Cell Lung Cancer with an EGFR Mutation

published 1 week ago by Dr Neil Love

Proceedings from a live CME webinar during the virtual IASLC 2020 North America  Conference on Lung Cancer. Featuring perspectives from Drs Roy S Herbst, Suresh S Ramalingam and Helena Yu on the following topics: Introduction (0:00) Overview of EGFR tumor mutations; selection of first-line therapy (1:20) First-line treatment of NSCLC with EGFR mutation and brain metastases (7:57) Progressive disease with EGFR mutation; resistance mutations (13:40) Management of locally advanced disease with EGFR mutation (22:23) ADAURA trial: Adjuvant therapy for NSCLC with EGFR mutation (31:08) Treatment of NSCLC with EGFR exon 20 alterations (43:23) Optimal approach to oligoprogression of NSCLC with EGFR mutation (50:27) CME information and select publications

more episodes from Research To Practice | Oncology Videos